4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001209191-22-042253
Chief Scientific Officer sold 1,916 shares at $30.00 ($57,480)
- Chief Scientific Officer acquired 1,916 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lachey Jennifer Chief Scientific Officer | 2022-07-13 | Option exercise | +1,916 | $0.30 | $575 | 93,184 | D |
| Lachey Jennifer Chief Scientific Officer | 2022-07-13 | Sale | −1,916 | $30.00 | $57,480 | 95,100 | D |
| Derivatives | |||||||
| Lachey Jennifer Chief Scientific Officer | 2022-07-13 | Option exercise · Employee Stock Option (right to buy) | −1,916 | 54,789 | D | ||
| Open-market sales · 1,916 sh · avg $30.00 · $57,480 | |||||||
Loading xslF345X03/doc4.xml…